Discover how circulating cell-free DNA (cfDNA) is transforming the diagnosis and monitoring of metabolic diseases like ...

VNRX READ THE FULL VNRX RESEARCH REPORT RECENT EVENTS Nu.Q Discover to be Utilized in a Human Clinical Study On March 4, 2025 ...

Scientists discovered a way to block hepatitis B infection using an anticancer drug, offering hope for new treatments.

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces that it has signed an agreement with a leading pharmaceutical company to utilize Volition's ...

and he is a speaker and consultant for Alnylam. Read the study: “A nucleosome switch primes Hepatitis B Virus infection,” Cell. DOI: 10.1016/j.cell.2025.01.033 ...

The study of cfDNA fragment length, an indirect measure of nucleosome positioning, has recently been shown to have good clinical utility. Fragmentomics can help to identify cancer and the tissue ...

The basic repeating structural (and functional) unit of chromatin is the nucleosome, which contains eight histone proteins and about 146 base pairs of DNA (Van Holde, 1988; Wolffe, 1999).

APCCC Diagnostics annual meeting featured a session on how to monitor metastatic prostate cancer and a presentation by Dr. Alexander Wyatt discussing when we should assess biology with ctDNA. Cell ...

Elizabeth Jamieson’s lab examines how various DNA lesions damage DNA. She and her students use differential scanning calorimetry to see how these lesions alter the thermodynamic stability of the DNA ...